Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Recommendation of “Reduce” from Brokerages

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have been assigned an average rating of “Reduce” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $1.80.

Separately, Deutsche Bank Aktiengesellschaft lifted their price target on Aveanna Healthcare from $2.00 to $3.00 and gave the company a “buy” rating in a research report on Monday, March 18th.

Aveanna Healthcare Stock Down 2.7 %

NASDAQ AVAH opened at $2.16 on Friday. The company has a market cap of $415.54 million, a PE ratio of -3.04 and a beta of 2.03. The firm’s 50-day simple moving average is $2.40 and its two-hundred day simple moving average is $2.20. Aveanna Healthcare has a 52 week low of $0.85 and a 52 week high of $3.00.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, March 14th. The company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. The business had revenue of $478.84 million for the quarter, compared to analysts’ expectations of $464.33 million. As a group, equities research analysts anticipate that Aveanna Healthcare will post -0.13 EPS for the current year.

Institutional Investors Weigh In On Aveanna Healthcare

Several institutional investors have recently added to or reduced their stakes in AVAH. Envestnet Asset Management Inc. raised its stake in shares of Aveanna Healthcare by 15.7% during the first quarter. Envestnet Asset Management Inc. now owns 26,363 shares of the company’s stock valued at $90,000 after acquiring an additional 3,569 shares during the last quarter. Swiss National Bank raised its position in Aveanna Healthcare by 7.4% during the 1st quarter. Swiss National Bank now owns 108,800 shares of the company’s stock valued at $371,000 after purchasing an additional 7,500 shares during the last quarter. Natixis Advisors L.P. lifted its holdings in Aveanna Healthcare by 18.0% in the 1st quarter. Natixis Advisors L.P. now owns 415,964 shares of the company’s stock worth $1,419,000 after buying an additional 63,365 shares during the period. MetLife Investment Management LLC grew its position in shares of Aveanna Healthcare by 54.9% in the 1st quarter. MetLife Investment Management LLC now owns 28,914 shares of the company’s stock worth $99,000 after buying an additional 10,246 shares during the last quarter. Finally, BlackRock Inc. increased its stake in shares of Aveanna Healthcare by 2.3% during the first quarter. BlackRock Inc. now owns 3,087,209 shares of the company’s stock valued at $10,526,000 after buying an additional 69,609 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.